Sanofi is using Kevzara, probably a good news for Corona treatment

French drug maker Sanofi and US company Regeneron Pharmaceuticals have begun using Kevzara to treat patients suffering from coronavirus hospitalization. It is reported that the drug is usually used when the glands and cells swell for unknown reasons. Kevzara also has government approval in the United States as a drug. Kevzara will be able to meet the expectations of Sanofi and Regeneron Pharmaceuticals, fever and oxygen deficiency in a Covid-19 patient.
Sanofi is working for combating Corona
This is a drug that has already been approved. The drug has undergone some side effects. Currently used in the treatment of Corona.
The drug is jointly manufactured by Sanofi and Regeneron Pharmaceuticals. It is being tested in two steps. It will be applied to a total of 400 patients. The first step will be to apply the drug to the Corona affected patients from sixteen areas of the United States. After giving the drug, the role of fever reduction and oxygen deficiency will also be investigated. According to Regeneron Pharmaceuticals Co-Founder, President and Chief Scientific Officer George Yankopoulos, IL-6 is found in the body of Coronavirus affected, according to China, which obstructs the lungs. Kevzara drugs will prevent that IL-6.
It is reported that coronavirus attacks lungs. And the IL-6 is responsible for this. IL-6 will be eliminated with the administration of Kevzara and lungs will be recoved to good condition.
Kevzara, is a research molecule of Regeneron to treat Corona
Basically, KEVZARA is a monoclonal antibody, was indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis. Notably, geriatric patients have had an inadequate response or intolerance to one or more disease-modifying antirheumatic drugs.
 According to Sanofi, the drug is currently being tested in New York of the United States. Later, it will be delivered to outside of the United States and different Corona affected areas, especially in Italy and other countries

Post a Comment

0 Comments